CHO Plus Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
8
CHO Plus General Information
Description
Developer of genetically engineered mammalian cells designed for the production of therapeutic proteins and viruses. The company utilizes patented technologies for cell engineering, genome transcription hotspots, and efficient clone screening, enabling biopharmaceutical companies to achieve higher productivity, reduce production costs, and enhance the capacity of existing manufacturing processes.
Contact Information
Website
www.cho-plus.comCorporate Office
- 329 Oyster Point Boulevard
- South San Francisco, CA 94080
- United States
Corporate Office
- 329 Oyster Point Boulevard
- South San Francisco, CA 94080
- United States
CHO Plus Timeline
CHO Plus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CHO Plus Patents
CHO Plus Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025265147-A1 | Packaging cells with tunable and leakproof gene expression to optimize production of aav vectors | Pending | 21-Jun-2024 | ||
| US-20260071231-A1 | Viral vector packaging cells with tunable virus genes to optimize vector production and quality | Pending | 21-Jun-2024 | ||
| EP-4824240-A1 | High production of recombinant protein by making cell hybrids and enriching for a preferred mitochondrial phenotype | Pending | 13-Dec-2023 | ||
| WO-2025128096-A1 | High production of recombinant protein by making cell hybrids and enriching for a preferred mitochondrial phenotype | Inactive | 13-Dec-2023 | ||
| AU-2023284396-A1 | Cell hybrids as host cells for high efficiency production of gene therapy vectors and viral vaccines | Pending | 09-Jun-2022 | C12N5/0686 |
CHO Plus Signals
CHO Plus Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CHO Plus FAQs
-
When was CHO Plus founded?
CHO Plus was founded in 2014.
-
Where is CHO Plus headquartered?
CHO Plus is headquartered in South San Francisco, CA.
-
What is the size of CHO Plus?
CHO Plus has 9 total employees.
-
What industry is CHO Plus in?
CHO Plus’s primary industry is Biotechnology.
-
Is CHO Plus a private or public company?
CHO Plus is a Private company.
-
What is CHO Plus’s current revenue?
The current revenue for CHO Plus is .
-
How much funding has CHO Plus raised over time?
CHO Plus has raised $440K.
-
Who are CHO Plus’s investors?
MedTech Innovator, BioTools Innovator, Johnson & Johnson Innovation - JLABS, MBC BioLabs, and LEONID are 5 of 6 investors who have invested in CHO Plus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process